4.7 Review

The prevalence, odds and predictors of lifespan comorbid eating disorder among people with a primary diagnosis of bipolar disorders, and vice-versa: Systematic review and meta-analysis

期刊

JOURNAL OF AFFECTIVE DISORDERS
卷 280, 期 -, 页码 409-431

出版社

ELSEVIER
DOI: 10.1016/j.jad.2020.11.015

关键词

Bipolar disorder; Anorexia nervosa; Bulimia nervosa; Binge eating disorder; Prevalence; Comorbidity; Review; Meta-analysis, Psychiatry, Mental health; Neuroscience

资金

  1. Health Education England (HEE) [ICA-CL-2017-03-001]
  2. National Institute for Health Research (NIHR) [ICA-CL-2017-03-001]
  3. NIHR Biomedical Research Centre at South London and Maudsley NHS Foundation Trust
  4. Medical Research Council
  5. Guys and St Thomas Charity (GSTT)
  6. COMPASS Pathways Limited
  7. Brain and Behavior Research Foundation
  8. Physician's Services Incorporated Foundation
  9. Stanley Medical Research Institute
  10. University of Toronto
  11. NHMRC Senior Principal Research Fellowship [1156072]
  12. AB-Biotics
  13. Abbott
  14. Allergan
  15. Angelini
  16. AstraZeneca
  17. Bristol-Myers Squibb
  18. Dainippon Sumitomo Pharma
  19. Farmindustria
  20. Ferrer
  21. Forest Research Institute
  22. Galenica
  23. Gedeon Richter
  24. Glaxo-Smith-Kline
  25. Janssen
  26. Lundbeck
  27. Otsuka
  28. Pfizer
  29. Roche
  30. Sage
  31. Sanofi-Aventis
  32. Servier
  33. Shire
  34. Sunovion
  35. Takeda
  36. Brain and Behaviour Foundation
  37. Generalitat de Catalunya (PERIS)
  38. Spanish Ministry of Science, Innovation and Universities (CIBERSAM)
  39. EU Horizon 2020

向作者/读者索取更多资源

Research indicates that the comorbidity rates of bipolar disorder (BD) and eating disorders (ED) vary across different diagnostic groups, rather than being determined by the direction between BD and ED. Future studies should focus on the risk, timeline, clinical impact, and management of comorbid BD and ED across different age groups.
Background: There are scarce and discrepant data about the prevalence and correlates of co-occurring eating disorders (EDs) among people with a primary diagnosis of bipolar disorder (BD), and vice-versa, compelling a systematic review and meta-analysis on the matter. Methods: MEDLINE/PsycINFO databases were systematically searched for original studies documenting BD reversible arrow ED comorbidity across the lifespan, from inception up until April 20th, 2020. Random-effects meta-analysis and meta-regression analyses were conducted, accounting for multiple moderators. Results: Thirty-six studies involved 15,084 primary BD patients. Eleven studies encompassed 15,146 people with primary EDs. Binge eating disorder (BED) occurred in 12.5% (95%C.I.=9.4-16.6%, I-2=93.48%) of BDs, while 9.1% (95%C.I.=3.3-22.6%) of BEDs endorsed BD. Bulimia Nervosa (BN) occurred in 7.4% (95%C.I.=6-10%) of people with BD, whereas 6.7% (95%C.I.=12-29.2%) of subjects with BN had a diagnosis of BD. Anorexia Nervosa (AN) occurred in 3.8% (95%C.I.=2-6%) of people with BDs; 2% (95%C.I.=1-2%) of BD patients had a diagnosis of AN. Overall, BD patients with EDs had higher odds of being female vs. non-ED controls. Several moderators yielded statistically significant differences both within- and between different types of BDs and EDs. Limitations: Scant longitudinal studies, especially across different EDs and pediatric samples. High heterogeneity despite subgroup comparisons. Limited discrimination of the quality of the evidence. Conclusions: The rates of BD reversible arrow ED comorbidity vary across different diagnostic groups, more than they do according to the direction of BD reversible arrow ED. Further primary studies should focus on the risks, chronology, clinical impact, and management of the onset of intertwined BD reversible arrow ED across different ages, promoting a continuum approach.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据